Measuring the cost-effectiveness of treating rectovaginal and vesicovaginal fistulas: A multicenter global study by the Fistula Foundation

被引:1
|
作者
Rajagopal, Keerthana [1 ,2 ]
Pollaczek, Lindsey [1 ]
Chu, Jesse [1 ]
Mann, Hannah [1 ]
机构
[1] Fistula Fdn, San Jose, CA USA
[2] Fistula Fdn, 1700 The Alameda 300, San Jose, CA 95126 USA
关键词
cost-effectiveness; disability-adjusted life-years; rectovaginal fistula; resource allocation; vesicovaginal fistula; OBSTETRIC FISTULA;
D O I
10.1002/ijgo.15502
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
ObjectiveSurgery for obstetric fistula is a highly effective treatment to restore continence and improve quality of life. However, a lack of data on the cost-effectiveness of this procedure limits prioritization of this essential treatment. This study measures the effectiveness of fistula surgeries using disability-adjusted life years (DALYs) averted.MethodsIn 2021 and 2022, the Fistula Foundation funded 20 179 fistula surgeries and related procedures at 143 hospitals among 27 countries. We calculated DALYs averted specifically for vesicovaginal fistula and rectovaginal fistula procedure types (n = 13 235 surgeries) by using disability weights from the 2019 Global Burden of Disease study. We based cost calculations on direct treatment expenses, including medical supplies, health provider fees, and preoperative and postoperative care. We measured effectiveness using data on the risk of permanent disability, country-specific average life spans, and treatment outcomes.ResultsThe total treatment cost was $7.6 million, and a total of 131 433 DALYs were averted. Thus, the cost per DALY averted-the cost to restore 1 year of healthy life-was $58. For this analysis, we took a cautious approach and weighted only surgeries that resulted in a closed fistula with restored continence. We calculated DALYs averted by country. Limitations of the study include data entry errors inherent in patient logs and lack of long-term outcomes.ConclusionThe current study demonstrates that obstetric fistula surgery, along with having a significant positive impact on maternal health outcomes, is highly cost-effective in comparison with other interventions. The study therefore highlights the benefits of prioritizing fistula treatment as part of the global agenda for maternal health care. Obstetric fistula treatment is highly cost-effective. The current study highlights the benefits of prioritizing fistula treatment as part of the global agenda for maternal health care.
引用
收藏
页码:480 / 486
页数:7
相关论文
共 50 条
  • [31] Global "burden of disease" -: Study for psychiatric -: Disorders rationale and application to the cost-effectiveness of mental health care interventions
    Üstün, TB
    Chisholm, D
    PSYCHIATRISCHE PRAXIS, 2001, 28 : S7 - S11
  • [32] The Cost-Effectiveness of Treating Childhood Cancer in Sub-Saharan Africa: Results From a Multicentre Study Across Four Countries
    Schroeder, K.
    Githang'A, J.
    Brown, B.
    Chitsike, I.
    Chekwenda-Makore, N.
    Majahasi, F.
    Ogundoyin, O.
    Petricca, K.
    Renner, L.
    Denburg, A.
    Gupta, S.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S35 - S35
  • [33] Cost-effectiveness of a bone substitute delivering gentamicin in the treatment of chronic osteomyelitis of long bones: Protocol for the CONVICTION randomized multicenter study
    Serrier, Hassan
    Huot, Laure
    Brosset, Sophie
    Batailler, Cecile
    Ferry, Tristan
    FRONTIERS IN MEDICINE, 2023, 10
  • [34] Cost-Effectiveness Analysis of Perioperative Oral Management after Cancer Surgery and an Examination of the Reduction in Medical Costs Thereafter: A Multicenter Study
    Sekiya, Hideki
    Kurasawa, Yasuhiro
    Maruoka, Yutaka
    Mukohyama, Hitoshi
    Negishi, Akihide
    Shigematsu, Shiro
    Sugizaki, Junpei
    Ohashi, Masaru
    Hasegawa, Shiro
    Kobayashi, Yutaka
    Ueno, Masayuki
    Michiwaki, Yukihiro
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (14)
  • [35] Assessment of global guidelines for preventive chemotherapy against schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study
    Lo, Nathan C.
    Lai, Ying-Si
    Karagiannis-Voules, Dimitrios-Alexios
    Bogoch, Isaac I.
    Coulibaly, Jean T.
    Bendavid, Eran
    Utzinger, Jurg
    Vounatsou, Penelope
    Andrews, Jason R.
    LANCET INFECTIOUS DISEASES, 2016, 16 (09): : 1065 - 1075
  • [36] Effectiveness and cost-effectiveness of primary arthrodesis versus open reduction and internal fixation in patients with Lisfranc fracture instability (The BFF Study) study protocol for a multicenter randomized controlled trial
    van den Boom, N. A. C.
    Stollenwerck, G. A. N. L.
    Evers, S. M. A. A.
    Poeze, M.
    BMC SURGERY, 2021, 21 (01)
  • [37] Effectiveness and cost-effectiveness of primary arthrodesis versus open reduction and internal fixation in patients with Lisfranc fracture instability (The BFF Study) study protocol for a multicenter randomized controlled trial
    N. A. C. van den Boom
    G. A. N. L. Stollenwerck
    S. M. A. A. Evers
    M. Poeze
    BMC Surgery, 21
  • [38] Cost-effectiveness of treating by simvastatin 40 mg/day high vascular risk patients: An economic evaluation based on the heart protection study
    Fagnani, F
    Lafuma, A
    Souchet, T
    VALUE IN HEALTH, 2003, 6 (06) : 657 - 657
  • [39] Cost-Effectiveness of Diffusion-Weighted Magnetic Resonance Imaging Versus Second-Look Surgery in Treating Cholesteatoma: A Modeling Study
    Bu, Daniel D.
    Schwam, Zachary G.
    Wanna, George B.
    Perez, Enrique
    Cosetti, Maura K.
    OTOLOGY & NEUROTOLOGY, 2024, 45 (02) : 163 - 168
  • [40] Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study
    Taylor, Douglas C. A.
    Pandya, Ankur
    Thompson, David
    Chu, Paula
    Graff, Jennifer
    Shepherd, James
    Wenger, Nanette
    Greten, Heiner
    Carmena, Rafael
    Drummond, Michael
    Weinstein, Milton C.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2009, 10 (03): : 255 - 265